PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director van den Broek Richard
May 19, 2023 16:18 ET
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Thorp Clay
May 19, 2023 16:18 ET
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Humphries William D.
May 19, 2023 16:18 ET
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HARRIGAN EDMUND
May 19, 2023 16:17 ET
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sapir Alex
May 19, 2023 16:17 ET
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Loewy Caroline M
May 19, 2023 16:16 ET
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hutson Nancy J
May 19, 2023 16:15 ET
PhaseBio Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.
Feb 14, 2023 16:45 ET
PhaseBio Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rock Springs Capital Management LP(0%),Rock Springs Capital LLC(0%), etc.
Feb 14, 2023 15:01 ET
PhaseBio Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(4.1%),Avidity Partners Management (GP) LLC(4.1%), etc.
Feb 14, 2023 14:26 ET
PhaseBio Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(0.00%),Wellington Group Holdings LLP(0.00%), etc.
Feb 6, 2023 15:02 ET
PhaseBio Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Nov 4, 2022 16:42 ET
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Oct 26, 2022 16:41 ET
PhaseBio Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MAI Capital Management, LLC(5.80%)
Jul 19, 2022 11:30 ET
PhaseBio Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Humphries William D.
Jun 10, 2022 16:20 ET
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
May 24, 2022 17:15 ET
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
May 24, 2022 17:14 ET
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
May 24, 2022 17:14 ET
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
May 24, 2022 17:13 ET
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
May 24, 2022 17:13 ET
No Data
No Data